FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

GSK PLC-SPON ADR reported third-quarter core profit of 54.6 pence per share on revenue of £8.89 billion, beating analyst expectations. The results topped consensus estimates of 50.4 pence per share and £8.84 billion respectively. The beat failed to sway investors, driving shares down 3.8% to £18.51 during morning trading.